论文部分内容阅读
目的:探讨不典型心力衰竭选择血管扩张剂临床疗效分析。方法:选择139例不典型心力衰竭患者,慢性肺心病55例,冠心病38例,肺心病合并冠心病30例,肺心病合并高血压心脏病16例。根据病种分别选用酚妥拉明、硝酸甘油和硝普钠治疗,观察疗效,进行临床分析。结果:通过合理选择使用血管扩张剂治疗不典型心力衰竭,疗效显著。结论:不典型心力衰竭选择不同血管扩张剂治疗,临床收效好,可降低病死率,使用安全。
Objective: To investigate the clinical efficacy of vasodilators in atypical heart failure. Methods: A total of 139 patients with atypical heart failure were selected, including 55 cases of chronic pulmonary heart disease, 38 cases of coronary heart disease, 30 cases of pulmonary heart disease complicated with coronary heart disease, and 16 cases of pulmonary heart disease complicated with hypertension heart disease. According to the disease were selected phentolamine, nitroglycerin and sodium nitroprusside treatment, observation of efficacy, clinical analysis. Results: The rational use of vasodilators in the treatment of atypical heart failure has a significant effect. Conclusion: Atypical heart failure choose different vasodilators treatment, clinical efficacy, reduce mortality and safe use.